1,127
Participants
Start Date
April 27, 2021
Primary Completion Date
September 30, 2023
Study Completion Date
June 30, 2024
Yangzheng Compound Mixture
"At the end of the treatment period, the investigator can decide whether to continue the medication based on the improvement of the subjects' sleep disturbance.~Medication during the follow-up period: subjects will enter the follow-up period after completing one course of Yangzheng Compound Mixture treatment or the end of the treatment period. Visits will be conducted once every 3 weeks, at least 2 times and no more than 4 times. For subjects in the experimental group, doctors can decide whether the patients should continue to receive Yangzheng Compound Mixture therapy in the follow-up period according to the improvement of sleep disorders, while for subjects in the control group, the patients can choose to start receiving Yangzheng Compound Mixture therapy in the follow-up period according to their own wishes and doctors' suggestions."
Conventional Treatment
Including treatment of sleep disorders and tumor which shall follow the clinical guidelines.
Shuguang Hospital Affiliated with Shanghai University of TCM, Shanghai
The Second Affiliated Hospital of Hunan University of Chinese Medicine, Changsha
Chongqing University Cancer Hospital, Chongqing
First Affiliated Hospital, Heilongjiang University of Chinese Medicine, Harbin
Jiamusi Cancer Hospital, Jiamusi
Henan Cancer Hospital, Zhengzhou
The Third Affiliated Hospital of Shandong First Medical University, Jinan
Zhongshan Hospital, Shanghai
Affiliated Hospital of Shanxi University of Chinese Medicine, Xianyang
Cancer Hospital of The University of Chinese Academy of Sciences, Hangzhou
LinkDoc Technology (Beijing) Co. Ltd.
INDUSTRY
Shaanxi Buchang Pharmaceutical Co., Ltd
INDUSTRY
ShuGuang Hospital
OTHER